News

Purdue Pharma launches new dosage of Butrans

BY Ryan Chavis

STAMFORD, Conn. — Purdue Pharma on Thursday announced the launch of a new dosage strength of 7.5 mcg/hour for its Butrans (buprenorphine) transdermal system CIII, bringing the total number of strengths offered by the company to five.
 
Butrans — a schedule III extended-release opioid — is the first transdermal system that delivers seven days of buprenorphine, according to the company. It may be called into the pharmacy, and refills may be given up to five times over the a six-month period, though refill guidelines may vary by state.
 
"We are proud to reach this milestone with the Butrans Transdermal System," said Todd Baumgartner, M.D., MPH, VP of research and development and chief medical officer at Purdue Pharma L.P. "The new 7.5 mcg/hour dosage strength can be an important tool for physicians managing the treatment of appropriate patients with chronic pain; the 7.5 mcg/hour dosage strength provides added flexibility when titrating from Butrans 5 mcg/hour." 
 
Butrans is used to manage pain that's severe enough to require daily, long-term opioid treatment. It was approved by the Food and Drug Administration in 2010. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

FDA issues draft guidance on pediatric acetaminophen products

BY Michael Johnsen

SILVER SPRING, Md. — The Food and Drug Administration earlier this month issued draft guidance with several recommendations for manufacturers of acetaminophen products, designed to help minimize the risk to consumers of liver damage associated with the use of pediatric liquids containing acetaminophen.
 
"FDA's recommendations are designed to encourage safer use of these products by minimizing the potential for acetaminophen overdosing due to medication errors or accidental ingestion," the agency noted in its announcement. "These recommendations apply to both single ingredient and combination ingredient OTC liquid oral drug products that are labeled for use by children under 12 years of age and contain acetaminophen."
 
According to the Acetaminophen Awareness Coalition, more than 50 million Americans use a medicine that contains acetaminophen — found in more than 600 different over-the-counter and prescription medicines including pain relievers, fever reducers, sleep aids and numerous cough, cold and flu medicines — each week. 
 
Among the recommendations made by FDA: 
 
  • All single-ingredient acetaminophen oral liquids for pediatric use should have a concentration of 160 mg acetaminophen per 5 mL;
  • For single-ingredient acetaminophen oral liquids, the statements “160 mg/5 mL” or “160 mg per 5 mL” should be prominently presented on the principal display panel of the container label and carton labeling immediately below or to the right of the active ingredient name (i.e., acetaminophen) and in the same font size as the active ingredient name;
  • The PDP should clearly indicate the age range and units of age (e.g., months or years) as stated in the Drug Facts Panel under the heading “Directions”;
  • The dosing directions in the Drugs Facts label should be provided only in milliliters (mL); and
  • The product package should include an appropriate dosage delivery device, such as a calibrated and labeled oral syringe or dosing cup that's calibrated in millileters (mL).
The Acetaminophen Awareness Coalition, a diverse group of leading health, healthcare provider and consumer organizations, formed the Know Your Dose campaign to educate consumers about safe acetaminophen use in order to prevent liver damage.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Jolen Creme Bleach celebrates 50 years

BY Antoinette Alexander

NEW YORK — Jolen Creme Bleach is celebrating its 50th anniversary with the first major packaging update since the product first graced the shelves.

While the logo and package color will remain the same, the new package design freshens up the brand’s look and offers two consumer bonuses: 20% more free product and a mixing cup to make it easier for blending the ingredients at home.

“Listening and responding to feedback from our loyal users led to the enhanced packaging,” said Jeff Kossak, VP of Jolen, a privately-held, family owned company headquartered in Fairfield, Conn. “Our popular Jolen Creme Bleach — original and sensitive formulas — will now feature a free bonus of 20% more product at the same price to help women lighten and soften hair on their face, arms and body. We're also providing a nifty, new mixing cup which makes it even easier to prepare the bleach.”
 
Launched in 1964 by entrepreneur and beauty pioneer Evelyn Kossak, who still plays an active role in the company, Jolen remains committed to helping women feel beautiful and confident.

“While our look on the outside has changed a bit, our mission as a company has remained the same over the past 50 years: to help women maximize their natural beauty by empowering them with confidence,” said Jolen president Kossak, who launched Jolen in 1964.
 
Jolen Creme Bleach is available in both original and sensitive formulas (with aloe vera) nationally in most major retailers, including Harmon, Rite Aid, Ulta Beauty, Walgreens and Walmart, as well as select beauty specialty stores and online.
 
Jolen will further mark the occasion with new advertising and promotions, a new website and the development of branded social media communities targeting beauty-focused consumers.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?